Ponatinib for Squamous Cell Lung Cancer
This study is currently recruiting participants.
Verified March 2013 by Dana-Farber Cancer Institute
Sponsor:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Peter S. Hammerman, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01761747
First received: September 26, 2012
Last updated: March 15, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |